Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias
批准号:
10525133
负责人:
Wilfried Rossoll
金额:
$218.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2025-08-31
关键词:
AddressAffectAffinity ChromatographyAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAnimal ModelAntibodiesAtrophicAutopsyBrainBrain regionCause of DeathCell Culture TechniquesCell modelCharacteristicsClinicComplexDataDementiaDetergentsDevelopmentDiseaseDisease ProgressionEnvironmentEtiologyFormalinFutureGoalsHumanImmunohistochemistryIn VitroInvestigationLabelLesionMAPT geneMass Spectrum AnalysisMethodsModelingMolecularMusNerve DegenerationNeurofibrillary TanglesNeurogliaNeuronsOrganoidsPathogenesisPathologicPathologyPathway interactionsPatientsPatternPick bodyPlayPost-Translational Protein ProcessingProcessPropertyProtein IsoformsProteinsProteomeProteomicsQuality ControlRefractoryResolutionRoleSamplingSignal TransductionTauopathiesTechnologyTestingToxic effectTransgenic MiceUnited StatesVariantbasebrain tissuecell typeclinical phenotypecohortdigitaleffective therapyhuman tissuein vivointerestmouse modelneuropathologynew therapeutic targetnovelnovel therapeutic interventionphosphoproteomicsprotein aggregationproteostasisresiliencespatiotemporaltau Proteinstau aggregationtau conformationtau phosphorylationtau-1
中文摘要
项目摘要/摘要
这个项目的目标是捕捉病理性tau相关蛋白的分子复杂性
通过邻近蛋白质组学对阿尔茨海默病(AD)及相关脑病患者的脑进行研究
从机制上理解它们在tau病理进展和相关神经退变中的作用。
以前的研究表明,微管的特征时间和拓扑模式之间存在相关性。
相关蛋白tau(MAPT)聚集与观察到的临床表型和进展
疾病。尽管神经原纤维缠结(NFT)和其他形式的磷酸-tau聚集体被认为是
在疾病过程中起着举足轻重的作用,我们对它的组成和分子了解很少
这些不溶性聚集体的环境,以及它们是如何形成、毒性和在大脑中扩散的
地区是受监管的。更好地了解阿尔茨海默病和原发性变态反应性疾病中的磷酸-tau相互作用体,
以及这些蛋白质如何调节受影响的tau的寡聚化、病理性堆积和播种。
神经元和神经胶质细胞对于识别新的治疗靶点至关重要。
由于当前技术的局限性,NFTs和其他神经病理学的深入特征
夹杂物历来很难解决,因为这些聚集体是不溶于洗涤剂的,因此
经典的亲和纯化方法难以获得。为了解决这一局限,我们建立了一部小说
病理性磷酸化tau蛋白的邻近标记、纯化和鉴定方法
从固定的人体组织中提取蛋白质,然后进行定量蛋白质组学分析。
我们假设病理性tau聚集体的分子环境对AD有贡献。
疾病过程,并建议使用最新的尖端技术来确定和比较
不同患者队列和疾病阶段的磷酸化tau相关蛋白质组,以破译分子
疾病发展中的信号网络,并从功能上验证人类AD的新治疗靶点
病例、小鼠模型和人体器官模型。我们的三个具体目标是:(I)比较tau病理-
通过邻近蛋白质组学的磷酸-tau包涵体的邻近蛋白质组学跨越常见的tau病
AD和原发性tau病患者的脑,(Ii)建立tau病理的时空模式-
AD患者队列中特定于疾病阶段、大脑区域和大脑弹性的相关蛋白质组,
以及(Iii)确定tau病理相关蛋白在神经退变过程中的功能作用
在人类阿尔茨海默病病例、小鼠模型和人脑有机化合物中。
该项目的成功完成将确定新的分子成分和细胞途径
调控AD和原发疾病的发病机制,可能为阿尔茨海默病提供新的治疗策略
对这些破坏性疾病的有效治疗。
英文摘要
PROJECT SUMMARY/ABSTRACT
The goal of this project is to capture the molecular complexity of pathological tau-associated proteins in the
brain of Alzheimer’s disease (AD) and related tauopathy patients via proximity-proteomics and gain a thorough
mechanistic understanding of their role in the progression of tau pathology and associated neurodegeneration.
Previous studies suggest a correlation of characteristic temporal and topological patterns of microtubule-
associated protein tau (MAPT) aggregates with the observed clinical phenotype and the progression of the
disease. Although neurofibrillary tangles (NFTs) and other forms of phospho-tau aggregates are believed to
play a pivotal role in the disease process, we have a poor understanding of the composition and molecular
environment of these insoluble aggregates, and how their formation, toxicity, and spread across the brain
regions is regulated. A better understanding of the phospho-tau interactome in AD and primary tauopathies,
and how these proteins regulate the oligomerization, pathological accumulation, and seeding of tau in affected
neurons and glia is of critical importance for the identification of novel therapeutic targets.
As a limitation of current technologies, the in-depth characterization of NFTs and other neuropathologic
inclusions has historically been difficult to address, since these aggregates are detergent-insoluble, and thus
refractory to classical affinity purification methods. To address this limitation, we have established a novel
method for the proximity-labeling, purification and identification of pathological phospho-tau associated
proteins from fixed human tissue followed by quantitative proteomics analysis.
We hypothesize that the molecular environment of pathological tau aggregates contributes to the AD
disease process and propose to use the latest cutting-edge technologies to determine and compare the
phospho-tau associated proteome across different patient cohorts and disease stages, to decipher molecular
signaling networks in disease development, and to functionally validate novel therapeutic targets in human AD
cases, mouse models, and human organoid models. Our three specific aims are: (i) to compare tau pathology-
associated proteomes across common tauopathies via proximity proteomics of phospho-tau inclusions in the
brain of AD and primary tauopathy patients, (ii) to establish spatiotemporal patterns of tau pathology-
associated proteomes specific for disease stages, brain regions, and brain resilience in AD patient cohorts,
and (iii) to determine the functional role of tau pathology-associated proteins in neurodegenerative processes
in human AD cases, mouse models, and human brain organoids.
Successful completion of this project will identify novel molecular components and cellular pathways
regulating the pathogenesis of AD and primary tauopathies, which may provide new therapeutic strategies for
effective treatment of these devastating disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUP50 as a modifier and risk factor for TDP-43 pathology in FTD/ALS
-
批准号:10800366
-
项目类别:
-
资助金额:$43.03万
-
财政年份:2023
-
负责人:Wilfried Rossoll
-
依托单位:
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias
-
批准号:10763607
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2022
-
负责人:Wilfried Rossoll
-
依托单位:
Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALS
-
批准号:10608681
-
项目类别:
-
资助金额:$73.05万
-
财政年份:2022
-
负责人:Wilfried Rossoll
-
依托单位:
RNA Processing Defects in SMA and Their Contribution to the Disease Phenotype
-
批准号:9098856
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2015
-
负责人:Wilfried Rossoll
-
依托单位:
RNA Processing Defects in SMA and Their Contribution to the Disease Phenotype
-
批准号:9265971
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2015
-
负责人:Wilfried Rossoll
-
依托单位:
Spinal Muscular Atrophy: Cell-based drug screens for treatment of axonal defects
-
批准号:7897178
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2010
-
负责人:Wilfried Rossoll
-
依托单位:
Spinal Muscular Atrophy: Cell-based drug screens for treatment of axonal defects
-
批准号:8049704
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2010
-
负责人:Wilfried Rossoll
-
依托单位:
Spinal muscular atrophy: a novel role of SMN in axonal ribonucleoprotein complexe
-
批准号:7293410
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2007
-
负责人:Wilfried Rossoll
-
依托单位:
Spinal muscular atrophy: a novel role of SMN in axonal ribonucleoprotein complexe
-
批准号:7473926
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2007
-
负责人:Wilfried Rossoll
-
依托单位:
海外基金